首页> 美国卫生研究院文献>other >Y-Shaped Bilateral Self-Expandable Metallic Stent Placement for Malignant Hilar Biliary Obstruction: Data from a Referral Center for Palliative Care
【2h】

Y-Shaped Bilateral Self-Expandable Metallic Stent Placement for Malignant Hilar Biliary Obstruction: Data from a Referral Center for Palliative Care

机译:Y型双侧自扩张金属支架用于恶性肝门胆管梗阻:来自姑息治疗转诊中心的数据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and Aim. Malignant hilar strictures are a clinical challenge because of the current therapeutic approach and the poor prognosis. In recent years, self-expandable metallic stents have proven more effective than plastic stents for palliation of malignant hilar strictures, with the bilateral stent-in-stent technique registering a high success rate. We report our experience with Y-shaped endoscopic self-expandable metallic stents placement for treatment of advanced malignant hilar strictures. Methods. From April 2009 to August 2012, we prospectively collected data on patients treated with Y-shaped SEMS placement for advanced malignant hilar carcinoma. Data on technical success, clinical success, and complications were collected. Results. Twenty patients (9 males) were treated (mean age 64.2 ± 15.3 years). The grade of malignant hilar strictures according to the Bismuth classification was II in 5 patients (25%), IIIa in 1 (5%), and IV in 14 (70%). The mean bilirubin level was 14.7 ± 4.9 mg/dL. Technical success was achieved in all patients, with a significant reduction in bilirubin levels (2.9 ± 1.7 mg/dL). One patient experienced cholangitis as early complication, while in 2 patients stent ingrowth was observed. No stents migration was recorded. There was no procedure-related mortality. At the end of the follow-up (7.1 ± 3.1 months), 13 of the 20 patients (65%) had died. Conclusions. Our experience confirms endoscopic bilateral self-expandable metallic stents placement with stent-in-stent technique (Y-shaped configuration) as a feasible, effective, and safe procedure for palliation of unresectable malignant hilar strictures.
机译:背景和目标。由于目前的治疗方法和不良的预后,恶性肺门狭窄是临床挑战。近年来,事实证明,自膨胀金属支架在缓解恶性肺门狭窄方面比塑料支架更有效,双侧支架支架技术的成功率很高。我们报告了我们的Y型内窥镜自膨胀金属支架置入术治疗晚期恶性肺门狭窄的经验。方法。从2009年4月至2012年8月,我们前瞻性收集了Y型SEMS放置治疗晚期恶性肺门癌患者的数据。收集有关技术成功,临床成功和并发症的数据。结果。治疗了20名患者(9名男性)(平均年龄64.2±15.3岁)。根据铋的分类,恶性肺门狭窄的等级为II级5例(25%),IIIa级1例(5%)和IV级14例(70%)。平均胆红素水平为14.7±4.9 mg / dL。所有患者均获得技术成功,胆红素水平显着降低(2.9±1.7 mg / dL)。一名患者因早期并发症而发生了胆管炎,而在两名患者中观察到支架向内生长。没有记录到支架迁移。没有与手术相关的死亡率。在随访结束时(7.1±3.1个月),20例患者中有13例(65%)死亡。结论。我们的经验证实,使用支架内支架技术(Y形配置)内窥镜双侧自扩张式金属支架置入术是治疗无法切除的恶性肺门狭窄的可行,有效和安全的程序。

著录项

  • 期刊名称 other
  • 作者

    R. Di Mitri; F. Mocciaro;

  • 作者单位
  • 年(卷),期 -1(2014),-1
  • 年度 -1
  • 页码 151502
  • 总页数 5
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号